A brief overview of the key points discussed during a company’s quarterly earnings call, including financial performance, guidance, and management’s commentary on future outlook.
PHC Holdings Earnings
Estimates
Actual
Y-on-Y Change
Revenue
EPS
Transcripts
Events
About PHC Holdings Corporation
PHC Holdings Corporation
6523
PHC Holdings Corporation, through its subsidiaries, provides medical devices, healthcare IT solutions, and life science products and services primarily in Japan. The company operates through Diabetes Management, Healthcare Solutions, and Diagnostic & Life Sciences segments. It offers blood glucose monitoring systems, continuous glucose monitoring systems, and diabetes application; patient and record billing software, including electronic medical record system, electronic medication history system, and healthcare note service; and diagnostic testing products, which include clinical testing, diagnostic reagents and instruments, and drug development support products. The company also provides biologic and cell preservation products, comprising low temperature freezers, CO2 incubators, and automatic tablet counting and packaging system; and cancer pathology products, which comprise tissue processor, microscopic slides, and cytology staining solutions. In addition, it develops and produces precision medical devices that help with early detection and ongoing monitoring of diseases, such as diabetes and asthma, and drug delivery systems that support medical treatment. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. PHC Holdings Corporation was founded in 1969 and is headquartered in Tokyo, Japan.
PHC Holdings Corporation, through its subsidiaries, provides medical devices, healthcare IT solutions, and life science products and services primarily in Japan. The company operates through Diabetes Management, Healthcare Solutions, and Diagnostic & Life Sciences seg...
PHC Holdings Corporation, through its subsidiaries, provides medical devices, healthcare IT solutions, and life science products and services primarily in Japan. The company operates through Diabetes Management, Healthcare Solutions, and Diagnostic & Life Sciences segments. It offers blood glucose monitoring systems, continuous glucose monitoring systems, and diabetes application; patient and record billing software, including electronic medical record system, electronic medication history system, and healthcare note service; and diagnostic testing products, which include clinical testing, diagnostic reagents and instruments, and drug development support products. The company also provides biologic and cell preservation products, comprising low temperature freezers, CO2 incubators, and automatic tablet counting and packaging system; and cancer pathology products, which comprise tissue processor, microscopic slides, and cytology staining solutions. In addition, it develops and produces precision medical devices that help with early detection and ongoing monitoring of diseases, such as diabetes and asthma, and drug delivery systems that support medical treatment. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. PHC Holdings Corporation was founded in 1969 and is headquartered in Tokyo, Japan.
Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach. Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.